Citadel Advisors’s Alpine Immune Sciences, Inc. Common Stock ALPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-142,879
| Closed | -$5.66M | – | 7101 |
|
|
2024
Q1 | $5.66M | Sell |
142,879
-732,378
| -84% | -$29M | ﹤0.01% | 1670 |
|
|
2023
Q4 | $16.7M | Buy |
875,257
+847,083
| +3,007% | +$16.1M | ﹤0.01% | 935 |
|
|
2023
Q3 | $323K | Sell |
28,174
-25,549
| -48% | -$293K | ﹤0.01% | 4195 |
|
|
2023
Q2 | $552K | Buy |
+53,723
| New | +$552K | ﹤0.01% | 3554 |
|
|
2023
Q1 | – | Sell |
-21,204
| Closed | -$156K | – | 6766 |
|
|
2022
Q4 | $156K | Buy |
+21,204
| New | +$156K | ﹤0.01% | 4825 |
|
|
2021
Q2 | – | Sell |
-22,030
| Closed | -$234K | – | 7264 |
|
|
2021
Q1 | $234K | Buy |
+22,030
| New | +$234K | ﹤0.01% | 5280 |
|
|
2016
Q1 | – | Sell |
-5,690
| Closed | -$176K | – | 4083 |
|
|
2015
Q4 | $176K | Buy |
+5,690
| New | +$176K | ﹤0.01% | 3008 |
|